STAT

STAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costs

STAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costsWorldPing

Analysts say private deals involve drugmakers agreeing to lower prices in Medicaid, where prices are low, in return for no price cuts in Medicare.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news